Alvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist for the treatment of opioid-induced bowel dysfunction: Results from a randomized, double-blind, placebo-controlled, dose-finding study in subjects taking opioids for chronic non-cancer painLynn R. Webster, Eric Carter, Gordon Irving et al.|Pain|2008Cited by 144
NGX-4010, a Capsaicin 8% Dermal Patch, Administered Alone or in Combination With Systemic Neuropathic Pain Medications, Reduces Pain in Patients With Postherpetic NeuralgiaGordon Irving, Geertrui F. Vanhove, Miroslav Bačkonja et al.|Clinical Journal of Pain|2011Cited by 68